Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DocGo Inc.DCGO · Entity 7359 | Chief Compliance Officer | December 31, 2021 | January 27, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DocGo Inc.
Report date December 31, 2021 · Filed January 27, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $8.80 · Expires 2031-12-07 | Direct | 1,000 |
Reported balance
After 2021-12-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-12-07 · Grant · Acquired 1,000 · Balance 1,000 F1: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 7, 2022 through December 7, 2025, in each cash, subject to the terms of the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan").
F2: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 7, 2022 through December 7, 2025, in each cash, subject to the terms of the Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 07, 2021 Filed Jan 27, 2022 17:04 UTC | DocGo Inc. DCGO · Entity 7359 | GrantOptions to purchase Common Stock · Derivative | 1,000 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001213900-22-004034 · ownership.xml · derivative · entry 1 Witkowski Michael S. · CIK 0001884698 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2031-12-07 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 7, 2022 through December 7, 2025, in each case, subject to the terms of the Plan. Read SEC document |
| December 07, 2021 Filed Jan 27, 2022 17:30 UTC | DocGo Inc. DCGO · Entity 7359 | GrantOptions to purchase Common Stock · Derivative | 1,000 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001213900-22-004075 · ownership.xml · derivative · entry 1 Witkowski Michael S. · CIK 0001884698 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2031-12-07 F1 · shares: Represents stock options granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"). F2 · derivative.exercise_date: The shares subject to the stock options vest and become exercisable in four equal annual installments beginning on December 7, 2022 through December 7, 2025, in each cash, subject to the terms of the Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.